Annexon, Inc. (ANNX)

CIK 0001528115 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-07) · 99.1
Latest FY-2025 8-K (2026-03-30) · 99.1
Q3-2025 8-K (2025-11-10) · 99.1
Q2-2025 8-K (2025-08-14) · 99.1
Q1-2025 8-K (2025-05-12) · 99.1
FY-2024 8-K (2025-03-03) · 99.1
Q3-2024 8-K (2024-11-14) · 99.1
Q2-2024 8-K (2024-08-12) · 99.1
Q1-2024 8-K (2024-05-13) · 99.1
FY-2023 8-K (2024-03-26) · 99.1
Q3-2023 8-K (2023-11-13) · 99.1  |  8-K (2023-05-08) · 99.1
Q2-2023 8-K (2023-08-07) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
—
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Stockholders' Equity (P)
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (P)
Notes
Balance Sheet Components
Basis of Presentation and Significant Accounting Policies
Commitments and Contingencies
Cybersecurity Risk Management, Strategy, and Governance Disclosure
—
Equity Incentive Plan
Fair Value Measurements
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Net Loss Per Share
Organization
Pay Vs Performance Disclosure
Segment Reporting
Stockholders' Equity